Loading
Latest filing published 31 Jul 2026 for Inhibikase Therapeutics, Inc., €24k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by Dennis N. Berman, dated 31 July 2026, reporting an option exercise worth €24k in Inhibikase Therapeutics, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration